STAGE III DISTAL BILE DUCT CANCER AJCC V8
Clinical trials for STAGE III DISTAL BILE DUCT CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III DISTAL BILE DUCT CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III DISTAL BILE DUCT CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for tough bile duct cancers
Disease control OngoingThis study tests whether adding the targeted drug binimetinib to standard chemotherapy (FOLFOX) can shrink tumors or help people with advanced bile duct or gallbladder cancer live longer. About 66 adults whose cancer has a specific genetic change (MAPK pathway mutation) and has w…
Matched conditions: STAGE III DISTAL BILE DUCT CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 04:37 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase trial tests a new drug (BAY 1895344) combined with standard chemotherapy in people with advanced solid tumors, especially bladder cancer. The goal is to find the safest dose and see how well the combination works. About 74 adults with cancers like lung, bladder, …
Matched conditions: STAGE III DISTAL BILE DUCT CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC